Myriad Genetics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $706.6M
Liabilities Breakdown FY2025
Total Liabilities: $338.6M
Asset Breakdown
Total Assets: $706.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $149.6M | 21.2% |
| Accounts Receivable | $115.3M | 16.3% |
| Inventory | $30.6M | 4.3% |
| Property, Plant & Equipment | $114.0M | 16.1% |
| Goodwill | $51.6M | 7.3% |
| Intangible Assets | $153.4M | 21.7% |
| Other Assets | $92.1M | 13.0% |
Liabilities Breakdown
Total Liabilities: $338.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $30.0M | 8.9% |
| Long-Term Debt | $119.9M | 35.4% |
| Other Liabilities | $188.7M | 55.7% |